Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06524791

Prevalence of Faecal Bacteriophage in Patients With Digestive Symptoms

Define the prevalence of fecal phage carriage in individuals with digestive symptoms (i) Determine the concentrations of infectious fecal phages in the stools of individuals with digestive symptoms (detection by culture)

(ii) Determine fecal phage genome concentrations in the stools of individuals with digestive symptoms (PCR detection)

(iii) Explore factors that could impact fecal phage carriage (patients with digestive symptoms vs. healthy individuals, immunocompromised patients vs. immunocompetent patients)

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Gastroenteritis Digestive System Diseases Gastrointestinal Diseases

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHRU Nancy

Nancy, 54000, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 18 and 60.
  • Persons having developed gastrointestinal symptoms justifying microbiological stool testing at the time of hospitalization.
  • Person having received full information on the organization of the research and not having objected to the use of this data

Exclusion criteria

  • Persons covered by articles L. 1121-5, L. 1121-7 and L1121-8 of the French Public Health Code.
  • Pregnant or breast-feeding women,
  • Minors (not emancipated),
  • Adult subject to a legal protection measure (guardianship, curatorship, safeguard of justice),
  • Persons of full age who are unable to give their consent.
  • Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care by virtue of articles L. 3212-1 and L. 3213-1.

Treatment and study plan

bacteriophage detection

Other

bacteriophage detection

Primary outcomes

  1. prevalence of faecal phage carriage

    Time frame: baseline

    define the prevalence of faecal phage (coliphage) carriage in individuals presenting with digestive symptoms.

Secondary outcomes

  1. concentrations of infectious fecal phages

    Time frame: baseline

    Determine the concentrations of infectious fecal phages in the stools of individuals with digestive symptoms (detection by culture)

  2. fecal phage genome concentrations

    Time frame: baseline

    determine fecal phage genome concentrations in the stools of individuals with digestive symptoms (PCR detection)

Study contacts

Contact information is provided by the study sponsor or research team.

Cédric Hartard

CONTACT

[email protected]

0383153046

Sponsors and collaborators

Lead sponsor

Central Hospital, Nancy, France

Other

Registry information

Official study title

Evaluation of the Prevalence of Faecal Bacteriophage Carriage in Patients With Digestive Symptoms.

Acronym: PREPHAGE

Important dates

Study start
2024
Primary completion
2024
Study completion
2025
First posted
Jul 29, 2024
Registry last updated
Jul 30, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.